HOME >> BIOLOGY >> NEWS
New studies on bone marrow failure diseases presented at scientific symposium Oct. 18-19

The latest advances in aplastic anemia, myelodysplastic syndromes (MDS), paroxysmal nocturnal hemoglobinuria (PNH) and other bone marrow failure diseases will be presented at the Bone Marrow Failure Scientific Symposium Oct. 18-19 in Washington, DC. This is the first international meeting covering all bone marrow diseases--life-threatening conditions for which, in most cases, the cause is unknown.

New research on stem cell transplantation, immunosuppressive treatments, drug therapies and alternative approaches will be presented by the world's leading physicians on bone marrow failure diseases.

The symposium is sponsored by the National Institutes of Health, including the Office of Rare Diseases, the National Heart, Lung and Blood Institute and the National Cancer Institute; and organized by Aplastic Anemia & MDS International Foundation, Inc. (AA&MDSIF). Co-chairs are Jaroslaw Maciejewski, MD, PhD, Cleveland Clinic Foundation, Taussig Cancer Center and Neal S. Young, MD, National Heart, Lung and Blood Institute.

More information on the symposium is at AA&MDSIF's web site: http://www.aamds.org

What:
Bone Marrow Failure Scientific Symposium

Who:
--National Heart, Lung and Blood Institute
--National Cancer Institute
--Office of Rare Diseases
--Aplastic Anemia & MDS International Foundation, Inc.

When:
Oct. 18-19, 2005

Where:
L'Enfant Plaza Hotel, 480 L'Enfant Plaza, Washington, DC
Press must register for the symposium. Accredited journalists receive complimentary registration.
To register contact: Brian Ruberry, 301-948-1709, br@allhealthpr.com.


'"/>

Contact: Brian Ruberry
br@allhealthpr.com
301-948-1709
Aplastic Anemia & MDS International Foundation
30-Sep-2005


Page: 1

Related biology news :

1. New studies on goats milk show it is more beneficial to health than cows milk
2. Berkeley Lab Life Sciences division awarded NIH grants for fruit fly, nematode studies
3. Obtaining valid consent for doing large genetic studies in developing countries
4. Short-term studies suggest that whole grain oats may reduce risk factors for coronary heart disease
5. New studies link the environment to Parkinsons disease
6. Ewwwww! UCLA anthropologist studies evolutions disgusting side
7. Genetic studies endow mice with new color vision
8. Epigenetic studies will provide a better understanding of disease
9. New mathematical model to add rigor to studies of disease genetics and evolution
10. Genes and groups of genes commonly shared between species, studies show
11. New bird, bat species revealed by extensive DNA barcode studies

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/11/2017)... PALM BEACH GARDENS, Fla. , April 11, ... biometric identity management and secure authentication solutions, today ... million contract by Intelligence Advanced Research Projects Activity ... technologies for IARPA,s Thor program. "Innovation ... the onset and IARPA,s Thor program will allow ...
(Date:4/11/2017)... 11, 2017 NXT-ID, Inc. (NASDAQ:   ... announces the appointment of independent Directors Mr. Robin D. ... Board of Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , ... forward to their guidance and benefiting from their considerable expertise ...
(Date:4/5/2017)... , April 5, 2017 Today HYPR ... that the server component of the HYPR platform is ... providing the end-to-end security architecture that empowers biometric authentication ... HYPR has already secured over 15 million users across ... manufacturers of connected home product suites and physical access ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... Disappearing forests ... the lives of over 5.5 million people each year. Especially those living in larger ... startup Treepex - based in one of the most pollution-affected countries globally - decided ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh ... orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of ... SBT-100 is able to cross the cell membrane and bind intracellular STAT3 and ...
(Date:10/10/2017)... CA (PRWEB) , ... October ... ... a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today ... of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder and CEO ... Diego Rotary Club. The event entitled “Stem Cells and Their Regenerative ... attendees. Dr. Harman, DVM, MPVM was joined by two human doctors: Peter B. ...
Breaking Biology Technology:
Cached News: